Disease: Corticobasal degeneration
- [<sup>18</sup>F]-FDopa positron emission tomography imaging in corticobasal syndrome
- [<sup>18</sup>F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration
- <em>In Silico</em> Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers
- A - 84 Neuropsychological Phenotypes of FDG-PET Identified Corticobasal Degeneration Pathology
- A non-invasive method for prediction of neurodegenerative diseases using gait signal features
- A Novel Brain PET Radiotracer for Imaging Alpha Synuclein Fibrils in Multiple System Atrophy
- A Rare Case of Asymmetric Progressive Supra Nuclear Palsy Diagnosed <em>In vivo</em> with Magnetic Resonance/Positron Emission Tomography
- Accuracy of routinely collected hospital administrative discharge data and death certificate ICD-10 diagnostic coding in progressive supranuclear palsy and corticobasal syndrome: a systematic review and validation study
- Age-Related Pathology in Corticobasal Degeneration
- Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension
- Amyloid-β prediction machine learning model using source-based morphometry across neurocognitive disorders
- Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?
- Anti-tau antibodies targeting a conformation-dependent epitope selectively bind seeds
- Association of Choroid Plexus Volume With Serum Biomarkers, Clinical Features, and Disease Severity in Patients With Frontotemporal Lobar Degeneration Spectrum
- Association of Neurofilament Light Chain, [<sup>18</sup>F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS
- Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia
- Asymmetric Cerebral Peduncle Atrophy: A Simple Diagnostic Clue for Distinguishing Frontotemporal Lobar Degeneration from Alzheimer's Disease
- Can multiple system atrophy clinically be misdiagnosed as corticobasal syndrome in the early stages?
- CBD and PSP cell-passaged Tau Seeds Generate Heterogeneous Fibrils with A sub-population Adopting Disease Folds
- Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias
- Clinical and MRI characterization of apraxic syndrome in corticobasal degeneration: A single-case study
- Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum
- Clinical course in corticobasal syndrome and corticobasal degeneration: implications for diagnosis and management
- Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome
- Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum
- Clinicoradiological and neuropathological evaluation of primary progressive aphasia
- Comparison of biospecimens for α-synuclein seed amplification assays in Parkinson's disease: A systematic review and network meta-analysis
- Correction to: Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome
- Cortico-basal syndrome and cortico-basal degeneration: From the clinical diagnosis to the lesional substrate for an adapted care
- Corticobasal degeneration with visual hallucination as an initial symptom: A case report
- Corticobasal syndrome mimicking Foix-Chavany-Marie syndrome with suggested 4-repeat tauopathy by tau PET
- Detailed Assessment of 18F-THK5351 Distribution Pattern in the Midbrain: Comparison With Progressive Supranuclear Palsy and Corticobasal Syndrome
- Detecting and Validating MAPT Mutations in Neurodegeneration Patients and Analysis of Exon Splicing Consequences
- Determinants of Astrocytic Pathology in Stem Cell Models of Primary Tauopathies
- Determinants of astrocytic pathology in stem cell models of primary tauopathies
- Diagnostic accuracy of cerebral [<sup>18</sup>F]FDG PET in atypical parkinsonism
- Differential Synaptic Loss in beta-Amyloid Positive Versus beta-Amyloid Negative Corticobasal Syndrome
- Disease-Associated Mutations in Tau Encode for Changes in Aggregate Structure Conformation
- Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies
- Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
- Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy
- Distinct tau folds initiate templated seeding and alter the post-translational modification profile
- Fiber-specific micro- and macroscopic white matter alterations in progressive supranuclear palsy and corticobasal syndrome
- Fluid and tissue biomarkers in Parkinson's disease: Immunodetection or seed amplification? Central or peripheral?
- Function and regulation of cis P-tau in the pathogenesis and treatment of conventional and nonconventional tauopathies
- Gene specific effects on brain volume and cognition of TMEM106B in frontotemporal lobar degeneration
- Genetic and sporadic forms of tauopathies-TAU as a disease driver for the majority of patients but the minority of tauopathies
- Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies
- Greater white matter degeneration and lower structural connectivity in non-amnestic vs. amnestic Alzheimer's disease
- Grey-matter correlates of empathy in 4-Repeat Tauopathies
- High sensitivity of asymmetric <sup>18</sup>F-THK5351 PET abnormality in patients with corticobasal syndrome
- Histological Study on the Thickness of Gray Matter at the Summit and Bottom of Folium in Different Age Groups of Bangladeshi People
- How Many Alzheimer-Perusini's Atypical Forms Do We Still Have to Discover?
- Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights
- Identification of metabolic pathways and key genes associated with atypical parkinsonism using a systems biology approach
- In vitro evaluation of [<sup>3</sup>H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies
- In vivo imaging of synaptic density in neurodegenerative disorders with positron emission tomography: A systematic review
- Interhemispheric reactivity of the subthalamic nucleus sustains progressive dopamine neuron loss in asymmetrical parkinsonism
- Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration
- Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson's disease
- Lateral geniculate body is spared of tau pathology in Pick disease
- Local structural preferences in shaping tau amyloid polymorphism
- Localizing apraxia in corticobasal syndrome: a morphometric MRI study
- Loss of Midbrain Dopamine Neurons Does Not Alter GABAergic Inhibition Mediated by Parvalbumin-Expressing Interneurons in Mouse Primary Motor Cortex
- Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?
- MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study
- Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
- Midbrain atrophy in pathologically diagnosed Lewy body disease and clinically diagnosed Parkinson's disease
- Monash-Alfred protocol for assessment of atypical parkinsonian syndromes (MAP-APS)
- Network connectivity alterations across the MAPT mutation clinical spectrum
- Neuroimaging-guided diagnosis of possible FTLD-FUS pathology: a case report
- Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer's disease and other neurodegenerative diseases
- Neuropathology of the Neurodegenerative Diseases
- Novel Conformation-Dependent Tau Antibodies Are Modulated by Adjacent Phosphorylation Sites
- Nucleus Basalis of Meynert degeneration predicts cognitive decline in Corticobasal Syndrome
- Parkinson-ALS with a novel MAPT variant
- Pathology of neurodegenerative disease for the general neurologist
- Pathomechanisms of cognitive and behavioral impairment in corticobasal degeneration
- PET imaging of synaptic density in Parkinsonian disorders
- Pick's disease presenting with corticobasal syndrome: A case report and clinicopathological review
- Polymerization of recombinant tau core fragments <em>in vitro</em> and seeding studies in cultured cells
- Probable 4-Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG-PET/MRI Neurodegeneneration Patterns in Corticobasal Syndrome
- Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies
- Progress in Primary Progressive Aphasia: A Review
- Progressive supranuclear palsy: A case report and brief review of the literature
- Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration
- Revisiting the relevance of Hirano bodies in neurodegenerative diseases
- Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
- Seeding Activity of Skin Misfolded Tau as a Biomarker for Tauopathies
- Spatiotemporal characteristics of neurophysiological changes in patients with four-repeat tauopathies
- Tau filaments from amyotrophic lateral sclerosis/parkinsonism-dementia complex adopt the CTE fold
- Tau in Atypical Parkinsonisms: A Meta-Analysis of in Vivo PET Imaging Findings
- The enigma of depression in corticobasal degeneration, a frequent but poorly understood co-morbidity
- The Role of Dual-Phase 18 F-FP-CIT PET to Early Diagnosis of Corticobasal Syndrome
- The Role of Dual-Phase 18F-FP-CIT PET to Early Diagnosis of Corticobasal Syndrome
- The tauopathies
- The therapeutic landscape of tauopathies: challenges and prospects
- Total Patient Delay: A Comparison of Patient and Clinician/Health System Delays in the Diagnosis of Progressive Supranuclear Palsy and Corticobasal Syndrome
- Two distinct degenerative types of nigrostriatal dopaminergic neuron in the early stage of parkinsonian disorders
- α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders